The Flow Cytometry Shared Resource (FCSR) provides state-of-the-art analytical and sorting instrumentation as well as cutting-edge expertise, to UCLA investigators needing flow cytometry for their research. The Jonsson Comprehensive Cancer Center (JCCC) established this shared resource in 1988. Beth Jamieson (Tl), has been the director of the FCSR since 2000. Ms. Ingrid Schmid, the manager of the FCSR since 1988, is responsible for the daily operation of the FCSR and assists Jamieson (Tl) with long-term planning. Both Jamieson (Tl) and Schmid are available to users for consultation. To achieve its goals, the FCSR houses five analytic flow cytometers, three high-speed FACSAria cell sorters, a RoboSep magnetic cell separator and a freestanding analysis station. The FCSR is easily accessible and is responsible for procurement, daily calibration, maintenance and repair of all instrumentation. FCSR personnel have a combined 98 years of experience in flow cytometry;their expertise is available to investigators through one-on-one consultation, frequent classes, a website, poster presentations and scheduled open houses. Schmid and Jamieson (Tl) also work with researchers to adapt or develop assays to enable investigators to pursue research questions in novel ways. FCSR services help researchers with a widely varied range of experience in flow cytometry to perform high quality assays with minimal time expenditure. Workshops, seminars and implementation of new assays ensure that researchers remain on the cutting-edge of flow cytometry without the necessity of investing their own funds or staff time to keep current in the latest advances. Cytometric instrumentation is expensive and beyond the budget of most individual researchers. Therefore, the FCSR provides instrumentation, as well as additional cost savings to researchers, by obtaining grant and institutional support to help offset the cost of purchasing, maintaining and operating those instruments. From 07/01/2011 to 06/30/2012, the FCSR had 170 users, 110 of whom were JCCC members, representing eight Cancer Center Program Areas. Of the 110 member users, 95 had peer-reviewed funding and 15 did not have peer-reviewed funding.

Public Health Relevance

): Preliminary data analysis by the CDC revealed that in 2010, neoplasms remained the second leading cause of death within the United States. The FCSR supports the work of JCCC investigators who strive to understand all aspects of cancer, ranging from its causes to its prevention and treatment. By supplying expertise and instrumentation that allow JCCC investigators to address novel research and clinical questions, the FCSR serves as a critical resource in the fight against cancer.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Los Angeles
Los Angeles
United States
Zip Code
Law, Ivy Ka Man; Jensen, Dane; Bunnett, Nigel W et al. (2016) Neurotensin-induced miR-133α expression regulates neurotensin receptor 1 recycling through its downstream target aftiphilin. Sci Rep 6:22195
Young, Courtney S; Hicks, Michael R; Ermolova, Natalia V et al. (2016) A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells. Cell Stem Cell 18:533-40
Palanichamy, Jayanth Kumar; Tran, Tiffany M; Howard, Jonathan M et al. (2016) RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation. J Clin Invest 126:1495-511
Van Dyk, Kathleen; Ganz, Patricia A; Ercoli, Linda et al. (2016) Measuring cognitive complaints in breast cancer survivors: psychometric properties of the patient's assessment of own functioning inventory. Support Care Cancer 24:4939-4949
Bostean, Georgiana; Crespi, Catherine M; Vorapharuek, Patsornkarn et al. (2016) E-cigarette use among students and e-cigarette specialty retailer presence near schools. Health Place 42:129-136
Aguilera-Sandoval, Christian R; Yang, Otto O; Jojic, Nebojsa et al. (2016) Supranormal thymic output up to 2 decades after HIV-1 infection. AIDS 30:701-11
Bauer, Margaret R; Harris, Lauren N; Wiley, Joshua F et al. (2016) Dispositional and Situational Avoidance and Approach as Predictors of Physical Symptom Bother Following Breast Cancer Diagnosis. Ann Behav Med 50:370-84
Horvath, Steve; Gurven, Michael; Levine, Morgan E et al. (2016) An epigenetic clock analysis of race/ethnicity, sex, and coronary heart disease. Genome Biol 17:171
Ganz, Patricia A; Petersen, Laura; Bower, Julienne E et al. (2016) Impact of Adjuvant Endocrine Therapy on Quality of Life and Symptoms: Observational Data Over 12 Months From the Mind-Body Study. J Clin Oncol 34:816-24
Dooley, Larissa N; Ganz, Patricia A; Cole, Steve W et al. (2016) Val66Met BDNF polymorphism as a vulnerability factor for inflammation-associated depressive symptoms in women with breast cancer. J Affect Disord 197:43-50

Showing the most recent 10 out of 568 publications